Position in RVMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$68,638,365
+$16,727,917 QoQ
Shares Held
705,793
+8.3% QoQ
Ownership
0.332%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 90.49537187248953.ToString("F0")%
Shared 0.ToString("F0")%
None 9.504628127510474.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. RVMD ranks #42 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in RVMD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $68,638,365 | 705,793 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $51,910,448 | 651,732 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $66,997,778 | 1,434,642 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $38,667,645 | 1,051,037 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $44,401,088 | 1,255,687 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $37,541,075 | 858,278 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $29,605,294 | 652,818 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $38,634,923 | 995,489 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $29,879,461 | 927,070 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $47,413,025 | 1,653,174 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $22,198,610 | 801,973 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $26,308,488 | 983,495 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,333,400 | 384,737 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,050,584 | 337,976 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,964,781 | 251,764 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,717,160 | 242,030 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $4,789,985 | 187,769 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,231,464 | 48,926 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,750,529 | 99,983 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $16,708,506 | 526,418 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $7,310,748 | 159,345 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,196,686 | 30,227 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,816,003 | 52,184 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $939,301 | 29,753 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,040,811 | 47,504 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||